Münger Karl, Howley Peter M
Department of Pathology, Harvard Medical School, Armenise Building 544, 200 Longwood Avenue, Boston, MA 02115-5701, USA.
Virus Res. 2002 Nov;89(2):213-28. doi: 10.1016/s0168-1702(02)00190-9.
The high risk HPVs (such as HPV-16 and HPV-18) that are associated with specific anogenital cancers encode two oncoproteins E6 and E7, which are expressed in the HPV positive cancers. The E7 protein functions in cellular transformation, at least in part, through interactions with pRB and the other pRB related 'pocket proteins'. The major target of the E6 oncoprotein encoded by the genital tract, cancer associated human papillomaviruses is p53. Several lines of evidence suggest that E6 and E7 have additional targets important to the oncogenic potential of the virus. Work from a number of laboratories has focused on determining other activities of HPV relevant to carcinogenesis and identifying additional cellular targets of E6 and E7. This paper will review the state of the field at the time of the 19th International Papillomavirus Workshop in September 2001 with respect to the HPV encoded oncoproteins.
与特定肛门生殖器癌症相关的高危型人乳头瘤病毒(如HPV - 16和HPV - 18)编码两种癌蛋白E6和E7,它们在HPV阳性癌症中表达。E7蛋白至少部分地通过与pRB及其他与pRB相关的“口袋蛋白”相互作用来发挥细胞转化功能。生殖道癌相关人乳头瘤病毒编码的E6癌蛋白的主要靶点是p53。多项证据表明,E6和E7还有其他对病毒致癌潜力很重要的靶点。许多实验室的研究工作集中在确定HPV与致癌作用相关的其他活性,并识别E6和E7的其他细胞靶点。本文将回顾2001年9月第19届国际乳头瘤病毒研讨会召开时该领域关于HPV编码癌蛋白的研究状况。